About GLP-1
GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone peptide involved in glucose homeostasis and widely used in metabolic research. Supplied as a lyophilized powder for laboratory investigations into incretin signaling, insulin secretion pathway markers, and glucagon regulation mechanisms in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Assessment of community awareness and attitude about the use of GLP 1 agonists as a treatment for obesity in Saudi Arabia: Cross-sectional study.
Recent research on GLP-1: Assessment of community awareness and attitude about the use of GLP 1 agonists as a treatment for obesity in Saudi Arabia: Cross-sectional study.
Read Full Study on PubMedClinical Outcomes Associated with the Use of a Family-Based Digital Support Program in Patients with Pharmacologic Treatment for Obesity.
Recent research on GLP-1: Clinical Outcomes Associated with the Use of a Family-Based Digital Support Program in Patients with Pharmacologic Treatment for Obesity.
Read Full Study on PubMedAdditional Studies
GLP-1 Receptor Agonists and SGLT2 Inhibitors in Stable Kidney Transplantation: Clinical Outcomes from a Cohort of Patients with Post-Transplant Diabetes Mellitus.
Recent research on GLP-1: GLP-1 Receptor Agonists and SGLT2 Inhibitors in Stable Kidney Transplantation: Clinical Outcomes from a Cohort of Patients with Post-Transplant Diabetes Mellitus.
Read on PubMedThe Impact of Glucagon-like Peptide-1 Receptor Agonists on Cardiovascular-Kidney-Metabolic Health in Romanian Patients with Type 2 Diabetes: A Retrospective Study.
Recent research on GLP-1: The Impact of Glucagon-like Peptide-1 Receptor Agonists on Cardiovascular-Kidney-Metabolic Health in Romanian Patients with Type 2 Diabetes: A Retrospective Study.
Read on PubMedTranslational Lifestyle Medicine Approaches to Cardiovascular-Kidney-Metabolic Syndrome.
Recent research on GLP-1: Translational Lifestyle Medicine Approaches to Cardiovascular-Kidney-Metabolic Syndrome.
Read on PubMedAcute Coronary Syndromes: State-of-the-Art Diagnosis, Management, and Secondary Prevention.
Recent research on GLP-1: Acute Coronary Syndromes: State-of-the-Art Diagnosis, Management, and Secondary Prevention.
Read on PubMedRelated Research
Purchase GLP-1 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.